“Polypill” reduces cardiovascular mortality by 33% in patients treated after a heart attack
A three-drug medication known as a “polypill,” developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in… read more.
